Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Yusuf Menda, University of Iowa
ClinicalTrials.gov Identifier:
NCT00721799
First received: June 10, 2008
Last updated: May 27, 2015
Last verified: May 2015